CONSENT AGREEMENT BETWEEN - State Medical Board of Ohio ...
CONSENT AGREEMENT BETWEEN - State Medical Board of Ohio ...
CONSENT AGREEMENT BETWEEN - State Medical Board of Ohio ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Matter <strong>of</strong> Kyle Elliott Hoogendoorn, D.P.M. Page 48<br />
Pt Date Procedure Type/<br />
Medication<br />
8 10/26/01 Trigger point injection/<br />
bupivacaine<br />
9 02/09/01 Trigger point injection/<br />
Depo-Medrol, bupivacaine<br />
02/16/01 Trigger point injection/<br />
Depo-Medrol, bupivacaine<br />
03/09/01 Trigger point injection/<br />
Depo-Medrol, bupivacaine<br />
11 05/28/01 Trigger point injection/<br />
Sarapin, Depo-Medrol,<br />
bupivacaine<br />
06/08/01 Trigger point injection/<br />
Depo-Medrol, bupivacaine<br />
06/19/01 Chemoneurolytic injection/<br />
Sarapin, bupivacaine<br />
08/28/01 Trigger point injection/<br />
Depo-Medrol, bupivacaine<br />
10/02/01 Chemoneurolytic injection/<br />
Sarapin, bupivacaine<br />
14 05/01/01 Trigger point injection/<br />
Depo-Medrol, bupivacaine<br />
05/08/01 Trigger point injection/<br />
Depo-Medrol, bupivacaine<br />
05/22/01 Chemoneurolytic injection/<br />
Sarapin, bupivacaine<br />
06/15/01 Chemoneurolytic injection/<br />
Sarapin, bupivacaine<br />
06/22/01 Trigger point injection/<br />
Depo-Medrol, bupivacaine<br />
17 01/19/01 Trigger point injection/<br />
bupivacaine<br />
01/26/01 Trigger point injection/<br />
Depo-Medrol, bupivacaine<br />
02/06/01 Chemoneurolytic<br />
injection 13 / Sarapin,<br />
Depo-Medrol, bupivacaine<br />
02/09/01 Chemoneurolytic injection/<br />
Sarapin, Depo-Medrol,<br />
bupivacaine<br />
02/16/01 Chemoneurolytic injection/<br />
Sarapin, bupivacaine<br />
Physician(s) Discharge Summary Signed By<br />
Dr. Leak or Dr. Griffin?/ Name<br />
Hoogendoorn/<br />
Griffin<br />
Hoogendoorn/<br />
Griffin<br />
Hoogendoorn/<br />
Leak<br />
Hoogendoorn/<br />
Griffin<br />
Hoogendoorn/<br />
Griffin<br />
Hoogendoorn/<br />
Griffin<br />
Hoogendoorn/<br />
Griffin<br />
Hoogendoorn/<br />
Griffin<br />
Hoogendoorn/<br />
Griffin<br />
Hoogendoorn/<br />
Griffin<br />
Hoogendoorn/<br />
Griffin<br />
Hoogendoorn/<br />
Griffin<br />
Hoogendoorn/<br />
Griffin<br />
Hoogendoorn/<br />
Griffin<br />
Yes/Griffin 127a<br />
Yes/Griffin 76a<br />
Yes/Griffin and Leak 74a<br />
Yes/Griffin 72a<br />
No 132a<br />
No 129a<br />
No 127a<br />
Yes/Griffin 113a<br />
Yes/Griffin 109a<br />
No 62a<br />
Possibly/Griffin 60a<br />
No 58a<br />
No 54a<br />
No 52a<br />
Hoogendoorn Yes/Griffin 113a<br />
Hoogendoorn Yes/Griffin 110a<br />
Hoogendoorn/<br />
Griffin<br />
Hoogendoorn/<br />
Griffin<br />
Hoogendoorn/<br />
Leak<br />
Yes/Leak 107a<br />
Yes/Griffin 104a<br />
Possibly/Leak 101a<br />
13 Many <strong>of</strong> the procedural notes for Patient 17 indicate that a trigger point injection was performed; however,<br />
Sarapin, a chemoneurolytic agent, was used. Accordingly, these procedures have been identified in this table as<br />
chemoneurolytic injections. (St. Ex. 17 at 173; see also pages 169-171)<br />
Dch.Sum<br />
at Page
Change language